“Why fit in, when you were born to stand out?” asks Venus the cat’s owner Christina, quoting Dr Seuss on Instagram where this striking case of heterochromia has two million followers.
The Asia Pacific TeleOphthalmology Society (APTOS) is launching a monthly webinar series on how telemedicine transforms clinical practice. The first session will run on 12 June (Friday) from 8-9pm
The government has released a new nationwide report on the condition and clinical fit-for-purpose assessment of the country’s District Health Board (DHB) facilities and buildings. “The government now
The Tear Film and Ocular Surface Society (TFOS) 2020 conference, scheduled for 9-12 September 2020 in Cernobbio, Italy, has been cancelled. The TFOS board of directors said the difficult decision
Researchers from Northwestern University in Illinois have found that a subset of retinal neurons sends inhibitory signals to the brain, contradicting the belief that the eye only sends excitatory signals.
Kiwi born and bred health intelligence and eye care referral company CatTrax is poised to sign partnership agreements with two of our leading eye disease patient support charities, Macular Degeneration New Zealand (MDNZ) and Glaucoma New Zealand (GNZ).
Auckland University’s School of Optometry and Vision Science (SOVS) is developing a virtual patient with pre-programmed ocular disorders for students to practice their clinical skills on during the Covid-19 restrictions and beyond.
A new open access literature analysis, Myopia Control 2020: Where are we and where are we heading? discusses a range of critically evaluated safety and efficacy considerations for behavioural, optical
UK researchers have found that Eplerenone, a drug used widely to treat central serous chorioretinopathy (CSCR), has “no benefit” and should no longer be used. Primarily used to treat heart
ESW Vision is hosting a series of virtual dry eye seminars featuring three international speakers: New Zealand’s Associate Professor Jennifer Craig, vice chair of TFOS DEWSII and head of Auckland
A new artificial intelligence (AI) algorithm developed by researchers at the New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD).
Due to the government’s Alert Level 3 restrictions, Eye Institute’s first 2020 seminar in the middle of May became a virtual affair, attracting nearly 400 New Zealand optometrists.
